Welcome to the USAID-funded Health Policy Plus (HP+) project website.

Links to documents and external sites open in a new window.

Health Policy Plus logoHealth Policy + logo
Skip to contentSkip to footer

Better Policy for Better Health

  • About
    • Project Overview
    • Partners
    • Leadership
    • Contact
    • Work with Us
    • Home
  • Our Work
    • Family Planning
    • HIV
    • COVID-19 Response
    • Health Financing
    • Maternal Health
    • Modeling
    • Capacity Development
    • Gender
    • Health Equity
  • Countries
    • Africa
    • Asia
    • Latin America & the Caribbean
  • Resources
    • Publications
    • Models
    • News
    • Viewpoints
    • Conferences & Events
    • Webinars

Project Impact

Impacts by Country    Impacts by Topic    Impacts by Year   

COVID-19 Vaccines: Needs, Lessons Learned and Recommendations for Effective Rollout

April 2021 — 

As part of the global effort to equitably supply vaccines to countries in need, HP+ convened academic and program implementation experts to share best practices, lessons learned, and tools to support rollout in low-resource countries. Under an accelerated effort, developing countries will be supported by the COVAX mechanism to immunize 20 percent of the population in 2021. The target group, scale, and intensity of this immunization campaign is significantly different than those handled by health ministries and immunization programs in the past. Joining the discussion to explore this were Ramon Soto of HP+’s COVID-19 response team in Honduras, Dr. Laila Woc-Colburn from Emory University’s School of Medicine, Dr. Edwin Asturias from the University of Colorado Denver, and Danielle Darrow de Mora of FHI 360. Key issues emerging from the discussion include strategies to deliver vaccines to hard-to-reach populations including migrants and indigenous populations and the need to include communities in rollout planning (microplanning). Panelists proposed effective strategies on the prevention, identification, and management of rare adverse events.

COVID-19 Vaccines: Needs, Lessons Learned and Recommendations for Effective Rollout

April 2021 — 

As part of the global effort to equitably supply vaccines to countries in need, HP+ convened academic and program implementation experts to share best practices, lessons learned, and tools to support rollout in low-resource countries. Under an accelerated effort, developing countries will be supported by the COVAX mechanism to immunize 20 percent of the population in 2021. The target group, scale, and intensity of this immunization campaign is significantly different than those handled by health ministries and immunization programs in the past. Joining the discussion to explore this were Ramon Soto of HP+’s COVID-19 response team in Honduras, Dr. Laila Woc-Colburn from Emory University’s School of Medicine, Dr. Edwin Asturias from the University of Colorado Denver, and Danielle Darrow de Mora of FHI 360. Key issues emerging from the discussion include strategies to deliver vaccines to hard-to-reach populations including migrants and indigenous populations and the need to include communities in rollout planning (microplanning). Panelists proposed effective strategies on the prevention, identification, and management of rare adverse events.

COVID-19 Vaccines: Needs, Lessons Learned and Recommendations for Effective Rollout

April 2021 — 

As part of the global effort to equitably supply vaccines to countries in need, HP+ convened academic and program implementation experts to share best practices, lessons learned, and tools to support rollout in low-resource countries. Under an accelerated effort, developing countries will be supported by the COVAX mechanism to immunize 20 percent of the population in 2021. The target group, scale, and intensity of this immunization campaign is significantly different than those handled by health ministries and immunization programs in the past. Joining the discussion to explore this were Ramon Soto of HP+’s COVID-19 response team in Honduras, Dr. Laila Woc-Colburn from Emory University’s School of Medicine, Dr. Edwin Asturias from the University of Colorado Denver, and Danielle Darrow de Mora of FHI 360. Key issues emerging from the discussion include strategies to deliver vaccines to hard-to-reach populations including migrants and indigenous populations and the need to include communities in rollout planning (microplanning). Panelists proposed effective strategies on the prevention, identification, and management of rare adverse events.

COVID-19 Vaccines: Needs, Lessons Learned and Recommendations for Effective Rollout

April 2021 — 

As part of the global effort to equitably supply vaccines to countries in need, HP+ convened academic and program implementation experts to share best practices, lessons learned, and tools to support rollout in low-resource countries. Under an accelerated effort, developing countries will be supported by the COVAX mechanism to immunize 20 percent of the population in 2021. The target group, scale, and intensity of this immunization campaign is significantly different than those handled by health ministries and immunization programs in the past. Joining the discussion to explore this were Ramon Soto of HP+’s COVID-19 response team in Honduras, Dr. Laila Woc-Colburn from Emory University’s School of Medicine, Dr. Edwin Asturias from the University of Colorado Denver, and Danielle Darrow de Mora of FHI 360. Key issues emerging from the discussion include strategies to deliver vaccines to hard-to-reach populations including migrants and indigenous populations and the need to include communities in rollout planning (microplanning). Panelists proposed effective strategies on the prevention, identification, and management of rare adverse events.

COVID-19 Vaccines: Needs, Lessons Learned and Recommendations for Effective Rollout

April 2021 — 

As part of the global effort to equitably supply vaccines to countries in need, HP+ convened academic and program implementation experts to share best practices, lessons learned, and tools to support rollout in low-resource countries. Under an accelerated effort, developing countries will be supported by the COVAX mechanism to immunize 20 percent of the population in 2021. The target group, scale, and intensity of this immunization campaign is significantly different than those handled by health ministries and immunization programs in the past. Joining the discussion to explore this were Ramon Soto of HP+’s COVID-19 response team in Honduras, Dr. Laila Woc-Colburn from Emory University’s School of Medicine, Dr. Edwin Asturias from the University of Colorado Denver, and Danielle Darrow de Mora of FHI 360. Key issues emerging from the discussion include strategies to deliver vaccines to hard-to-reach populations including migrants and indigenous populations and the need to include communities in rollout planning (microplanning). Panelists proposed effective strategies on the prevention, identification, and management of rare adverse events.

Related Materials

Reflections from the HP+ End-of-Project Learning Exchange
Reflections from the HP+ End-of-Project Learning Exchange
Messages of Hope: Reaching Boys and Men with  HIV and AIDS Information
Messages of Hope: Reaching Boys and Men with HIV and AIDS Information
Guatemala's Tailored, Rural Vaccination Plan Strengthens COVID-19 Vaccine Coverage
Guatemala's Tailored, Rural Vaccination Plan Strengthens COVID-19 Vaccine Coverage

Tags

    Global    
Equity     Indigenous Groups     Best Practices     COVID-19        
  • About
    • Project Overview
    • Partners
    • Leadership
    • Contact
    • Work with Us
    • Home
  • Our Work
    • Family Planning
    • HIV
    • COVID-19 Response
    • Health Financing
    • Maternal Health
    • Modeling
    • Capacity Development
    • Gender
    • Health Equity
  • Countries
    • Africa
    • Asia
    • Latin America & the Caribbean
  • Resources
    • Publications
    • Models
    • News
    • Viewpoints
    • Conferences & Events
    • Webinars
Privacy Policy Sitemap Staff Intranet

CONTACT US

Health Policy Plus
1331 Pennsylvania Ave NW, Suite 600
Washington, DC 20004
policyinfo@thepalladiumgroup.com

Health Policy Plus (HP+) is a seven-year cooperative agreement funded by the U.S. Agency for International Development under Agreement No. AID-OAA-A-15-00051, beginning August 28, 2015. HP+ is implemented by Palladium, in collaboration with Avenir Health, Futures Group Global Outreach, Plan International USA, Population Reference Bureau, RTI International, ThinkWell, and the White Ribbon Alliance for Safe Motherhood.

USAID-from the American People

The information provided on this website is not official U.S. Government information and does not necessarily represent the views or positions of the U.S. Agency for International Development.

Hosting and © 2016 by For technical issues contact us.webmaster@thepalladiumgroup.com.